Clinical utilization of blinatumomab and inotuzumab immunotherapy in children with relapsed or refractory B-acute lymphoblastic leukemia. - Contreras CF; Higham CS; Behnert A; Kim K; Stieglitz E; Tasian SK (Pediatric blood & cancer, 2021)